Top Stock Movers Now: Moderna, 3M, Walgreens, and More
U.S. equities rose at midday on optimism the new tariffs threatened by President Trump won't be as severe as initially believed.
U.S. equities rose at midday on optimism the new tariffs threatened by President Trump won't be as severe as initially believed.
Union says Kroger-owned retailers failed to meet on several concerns
Intel shares rose again Tuesday after surging more than 12% last week amid speculation the chipmaker is a takeover target. Monitor these crucial chart levels.
Shares of Trump Media & Technology Group, which owns the Truth Social platform, were recently down about 10%.
The campaign resulted in double revenue performance and set a new standard in interactive customer messaging.
Walgreens shares sank Tuesday, the first day of trading since the Department of Justice announced a lawsuit accusing the pharmacy chain of dispensing "millions of unlawful prescriptions" with no legitimate medical purpose.
Tuesday, Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On Friday, Moderna announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administr
(Bloomberg) -- European equities rose on Tuesday on relief that US President Donald Trump had refrained from immediately targeting the region with trade tariffs.Most Read from BloombergTexas HOA Charged With Discrimination for Banning Section 8 RentersHow Sanctuary Cities Are Preparing for Another Showdown With TrumpWhat LA’s Fires Mean for the City’s Housing ShortageNY’s Hochul Calls for Law Banning Cell Phone Use in SchoolsDonations to LA Fire Victims Rise Past $200 Million MarkThe Stoxx Europ
Shares of industrial conglomerate 3M (NYSE:MMM) jumped 6.1% in the pre-market session after the company reported fourth-quarter results, which exceeded analysts' revenue and EPS expectations. On the other hand, its full-year EPS guidance fell slightly short of Wall Street's estimates. Zooming out, we think this was a decent quarter featuring some areas of strength but also some blemishes.
Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) fell 12.3% in the morning session after the US Department of Justice accused the company (Walgreens) of filling millions of unlawful opioid prescriptions. According to the complaint, Walgreens overlooked major red flags and pressured pharmacists to dispense these medications, then sought reimbursement from federal programs in violation of the False Claims Act. Although Walgreens denies any wrongdoing, the stock's reaction suggests in